Solifenacin Stada 5 mg filmom obložene tablete
| Name | Solifenacin Stada 5 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-242513315 |
| Active Substance | solifenacinsukcinat |
| Composition | jedna filmom obložena tableta sadrži 5 mg solifenacinsukcinata, što odgovara 3,8 mg solifenacina |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | STADA Arzneimittel AG, Bad Vilbel, Njemačka STADA Arzneimittel GmbH, Beč, Austrija Clonmel Healthcare Ltd., Clonmel, Co. Tipperary, Irska Centrafarm Services B.V., Breda, Nizozemska Stada M&D S.R.L., Turda, Rumunjska Ibs-Experts International d.o.o., Zaprešić, Hrvatska |
| Marketing Authorisation Holder | Stada d.o.o., Hercegovačka 14, Zagreb, Hrvatska |
| Marketing Authorisation Date | 10.03.2022 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/21-02/149 |
| Registration Number | 381-12-01/154-22-03 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | G04BD08 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
